Inogen sets terms for $75 million IPO


Shutterstock photo

Inogen, which sells portable oxygen concentrators for patients suffering from chronic respiratory conditions, announced terms on Tuesday for its IPO. The Goleta, CA-based company plans to raise $75 million by offering 4.4 million shares (20% insider) at a price range of $16 to $18. At the midpoint of the proposed range, Inogen would command a fully diluted market value of $342 million.

Inogen, which was founded in 2001 and booked $70 million in sales for the 12 months ended September 30, 2013, plans to list on the NASDAQ under the symbol INGN. Inogen initially filed confidentially on October 16, 2013. J.P. Morgan is the sole bookrunner on the deal.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: News Headlines , IPOs

More from Renaissance Capital


Renaissance Capital

Renaissance Capital

Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by